Incorporating HIV/HCV Prevention, Screening, and Linkage to Care Into Opioid Use Disorder Treatment Settings

CCO commentary by Jennifer Cocohoba, PharmD, on how to avoid polypharmacy in aging patients with HIV

Jennifer Cocohoba, PharmD Released: October 12, 2020

CCO slides on ending the HIV epidemic in the United States via expanded testing, enhanced linkage to care, and rapid response to potential outbreaks

Lisa K. Fitzpatrick, MD, MPH, MPA David Malebranche, MD, MPH Released: October 7, 2020

Downloadable PDF resource from CCO on HCV and HIV screening essentials and HIV PrEP basics for addiction medicine specialists

Andrew Seaman, MD Released: October 2, 2020

Expert-authored CCO slides on current and future HIV prevention strategies, including FTC/TDF and FTC/TAF PrEP and long-acting injectable PrEP

W. David Hardy, MD
Program Director Gregory Huhn, MD, MPHTM Released: September 25, 2020